JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area tgf tgf bcr abl'

Search results for: 'research area tgf tgf bcr abl'

A3808 SD-208

Summary: TGF-βR I kinase inhibitor

≥8.95 mg/mL
A3799 SB-505124 hydrochloride

Target: ALK

Summary: ALK5/ALK4/ALK7 inhibitor in TGF-β/activin signalling,selective
A8464 LY2109761

4 Citation

Summary: TβRI/II kinase inhibitor

≥22.1 mg/mL
A5602 SB525334

Summary: (TGF-beta1) receptor inhibitor

≥34.3 mg/mL
A8348 LY2157299

2 Citation

Summary: TGF-βR1 inhibitor,potent and selective

insoluble in H2O; ≥18.45 mg/mL
A8301 GW788388

Summary: ALK5 inhibitor,potent and selective

≥21.25 mg/mL
A3132 A 77-01

Summary: Potent ALK5 inhibitor

insoluble in H2O; ≥14.3 mg/mL
A3133 A 83-01

Summary: ALK-5 inhibitor

≥21.1 mg/mL
A8232 Nilotinib(AMN-107)

1 Citation

Target: Bcr-Abl

Summary: Bcr-Abl kinase inhibitor,selective

≥26.5 mg/mL
A8604 GNF 5

Target: Bcr-Abl

Summary: Bcr-Abl inhibitor